Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00289
|
|||||
| Drug Name |
Vitamin C
|
|||||
| Synonyms |
(2R)-2-[(1S)-1,2-Dihydroxyethyl]-4,5-dihydroxy-furan-3-one; (2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one; (5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one; 2-(1,2-Dihydroxyethyl)-4,5-dihydroxyfuran-3-one; 3-Keto-L-gulofuranolactone; 3-Oxo-L-gulofuranolactone; 3-Oxo-L-gulofuranolactone (enol form); Acid Ascorbic; Acide ascorbique; Acide ascorbique [INN-French]; Acido ascorbico; Acido ascorbico [INN-Spanish]; Acidum ascorbicum; Acidum ascorbicum [INN-Latin]; Acidum ascorbinicum; Adenex; Allercorb; Antiscorbic vita min; Antiscorbic vitamin; Antiscorbutic factor; Antiscorbutic vitamin; Arco-cee; Ascoltin; Ascoltin (TN); Ascor-B.I.D.; Ascor-b.i.d; Ascorb; Ascorbajen; Ascorbate; Ascorbic Acid, Monosodium Salt; Ascorbic acid; Ascorbic acid (JP15/USP/INN); Ascorbic acid [BAN:INN:JAN]; Ascorbic acid [INN:BAN:JAN]; Ascorbicab; Ascorbicap; Ascorbicap (TN); Ascorbicin; Ascorbinsaeure; Ascorbutina; Ascorbyl radical; Ascorin; Ascorteal; Ascorvit; C-Level; C-Long; C-Quin; C-Span; C-Vimin; CE-VI-Sol; Cantan; Cantaxin; Catavin C; Ce lent; Ce-Mi-Lin; Cebicure; Cebid; Cebion; Cebione; Cecon; Cee-Vite; Cee-caps td; Cegiolan; Ceglion; Celaskon; Celin; Cemagyl; Cemill; Cenetone; Cenolate; Cereon; Cergona; Cescorbat; Cetamid; Cetane-Caps TC; Cetane-Caps TD; Cetebe; Cetemican; Cevalin; Cevatine; Cevex; Cevi-Bid; Cevibid; Cevimin; Cevital; Cevitamic acid; Cevitamin; Cevitan; Cevitex; Cewin; Ciamin; Cipca; Citriscorb; Colascor; Component of Cortalex; Component of E and C-Level; Component of Endoglobin Forte; Component of Ferancee; Concemin; Cortalex; Davitamon C; Dora-C-500; Duoscorb; Ferancee; Ferrous ascorbate; Hicee; Hybrin; IDO-C; Iron(II) ascorbate; Iron-ascorbic acid complexes;L-Ascorbic acid; Kyselina askorbova; Kyselina askorbova [Czech]; L(+)-Ascorbic acid; L-(+)-Ascorbic Acid; L-3-Ketothreohexuronic acid lactone; L-3-ketothreohexuronic acid; L-Ascorbic acid, free radical form; L-Lyxoascorbic acid; L-Threoascorbic acid; L-Xyloascorbic acid; L-ascorbate; L-ascorbic acid; L-threo-Hex-2-enonic acid, gamma-lactone; L-threo-ascorbic acid; L-threo-hex-1-eofuranos-3-ulose; L-threo-hex-2-enono-1,4-lactone; Laroscorbine; Lemascorb; Liqui-Cee; Magnesium Ascorbicum; Magnorbin; Meri-C; Monodehydroascorbic acid; Natrascorb; Natrascorb injectable; Oral Vitamin C; Planavit C; Proscorbin; Redoxon; Ribena; Roscorbi c; Roscorbic; Scorbacid; Scorbu-C; Secorbate; Semidehydroascorbate; Sodascorbate; Sodium Ascorbate (Ascorbic Acid); Stuartinic; Sunkist; Testascorbic; Tolfrinic; Vicelat; Vicin; Vicomin C; Viforcit; Viscorin; Vitace; Vitacee; Vitacimin; Vitacin; Vitamin-C; Vitamisin; Vitascorbol; Xitix
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Vitamin C deficiency [ICD11: 5B56] | Approved | [1] | |||
| Therapeutic Class |
Vitamins
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C6H8O6
|
|||||
| Canonical SMILES |
C(C(C1C(=C(C(=O)O1)O)O)O)O
|
|||||
| InChI |
InChI=1S/C6H8O6/c7-1-2(8)5-3(9)4(10)6(11)12-5/h2,5,7-10H,1H2/t2-,5+/m0/s1
|
|||||
| InChIKey |
CIWBSHSKHKDKBQ-JLAZNSOCSA-N
|
|||||
| CAS Number |
CAS 50-81-7
|
|||||
| Pharmaceutical Properties | Molecular Weight | 176.12 | Topological Polar Surface Area | 107 | ||
| Heavy Atom Count | 12 | Rotatable Bond Count | 2 | |||
| Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
-1.6
|
|||||
| PubChem CID | ||||||
| PubChem SID |
11528251
, 14717141
, 15219590
, 15321981
, 17390038
, 22395201
, 24855464
, 24859847
, 24871532
, 24890105
, 24890106
, 24890107
, 24890417
, 24890632
, 24890635
, 24890649
, 24890857
, 24890875
, 24891042
, 24891246
, 24891432
, 24900863
, 26757776
, 29203862
, 29224819
, 3132038
, 3372
, 36507993
, 46505070
, 47662544
, 47960008
, 48259498
, 48413235
, 48415580
, 48416719
, 48423587
, 48425237
, 49684275
, 49699000
, 49737747
, 50105612
, 53790060
, 56310862
, 56313946
, 56314017
, 597821
, 7847086
, 7885976
, 8145471
, 828416
|
|||||
| ChEBI ID |
ChEBI:29073
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | SVCT1 | Transporter Info | Sodium-dependent vitamin C transporter 1 | Substrate | [2] | |
| SVCT2 | Transporter Info | Sodium-dependent vitamin C transporter 2 | Substrate | [3] | ||
| References | ||||||
| 1 | Vitamin C was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | A family of mammalian Na+-dependent L-ascorbic acid transporters. Nature. 1999 May 6;399(6731):70-5. | |||||
| 3 | Molecular characterization and transcriptional regulation of the sodium-dependent vitamin C transporter genes (slc23a1 and slc23a2) in a teleost fish, the Senegalese sole (Solea senegalensis). Comp Biochem Physiol B Biochem Mol Biol. 2012 Mar;161(3):208-18. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.